c-Myc is essential for urokinase plasminogen activator expression on hypoxia-induced vascular smooth muscle cells

Cardiovasc Res. 2007 Jul 1;75(1):186-94. doi: 10.1016/j.cardiores.2007.02.033. Epub 2007 Mar 3.

Abstract

Objectives: The purpose of this study was to investigate whether c-Myc regulates expression of urokinase plasminogen activator (uPA) on hypoxia-induced vascular smooth muscle cells (VSMCs).

Methods: VSMCs were isolated from thoracic aorta of wild-type (WT), tissue plasminogen activator (tPA) and uPA-deficient mice. Gene and protein expression levels were examined by reverse-transcription PCR and Western blotting, respectively. c-Myc and uPA transcriptional activity were determined by luciferase analysis. Zymography analysis was used to test the activity of matrix metalloproteinases (MMPs), tPA, and uPA.

Results: Hypoxia significantly promoted WT and tPA-/- VSMC migration and invasion. However, uPA-/- severely decreased hypoxia-induced VSMC migration and invasion. Hypoxia increased uPA and MMP-2 activity, while uPA-/- decreased hypoxia-induced MMP-2 activity. c-Myc expression and transcriptional activity were increased in response to hypoxia, and silenced c-Myc abolished hypoxia-induced uPA and MMP-2 activity. In addition, hypoxia-induced Bcl2 expression and Bcl2 binding to c-Myc led to enhanced c-Myc-mediated uPA and MMP-2 activity in response to hypoxia.

Conclusions: The results show that c-Myc was essential for hypoxia-induced uPA expression and activity, resulting in VSMC migration and invasion. In addition, Bcl2 enhanced the c-Myc-mediated uPA/MMP-2 pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Vessels
  • Blotting, Western / methods
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Electrophoresis, Polyacrylamide Gel
  • Gene Expression
  • Genes, bcl-2
  • Genes, myc
  • Hypoxia / metabolism*
  • Luciferases / genetics
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism
  • Mice
  • Mice, Knockout
  • Myocytes, Smooth Muscle / metabolism*
  • Proto-Oncogene Proteins c-myc / metabolism*
  • RNA Interference
  • RNA, Small Interfering / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tissue Plasminogen Activator / genetics
  • Tissue Plasminogen Activator / metabolism
  • Urokinase-Type Plasminogen Activator / genetics
  • Urokinase-Type Plasminogen Activator / metabolism*

Substances

  • Proto-Oncogene Proteins c-myc
  • RNA, Small Interfering
  • Luciferases
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinases